Technical analysis of Biofrontera Inc. (BFRI): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Price Performance
| 1 month | -15.97% |
| 3 months | +22.59% |
| Year-to-date | +112.28% |
| 1 year | +42.35% |
| 3 years | -86.00% |
52-Week Range
| 52-week High | $1.66 |
| 52-week Low | $0.55 |
| Avg Volume (90d) | 464K |
Technical Indicators
| SMA 50 | $1.29 |
| SMA 200 | $1.00 |
| Beta | 0.64 |
| 30-day Volatility (annualised) | 75.1% |
| Price vs SMA 50 | -6.5% |
| Price vs SMA 200 | +20.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.10 | |
| 2025-11 | $0.82 | -25.7% |
| 2025-12 | $0.57 | -30.2% |
| 2026-01 | $0.93 | +63.2% |
| 2026-02 | $0.91 | -2.0% |
| 2026-03 | $0.81 | -11.3% |
| 2026-04 | $1.08 | +33.5% |
| 2026-05 | $0.89 | -18.0% |
| 2026-06 | $0.95 | +6.7% |
| 2026-07 | $1.17 | +23.7% |
| 2026-08 | $1.53 | +30.8% |
| 2026-09 | $1.21 | -20.9% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | $144M |
| 2026-09-14 | | $898M |
Price
| Price | $1.21 |
| Market Cap | $15M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.78 |
| EV / EBITDA | -4.17 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 1.26 |
| Current Ratio | 1.18 |